{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T10:10:10Z","timestamp":1768990210476,"version":"3.49.0"},"reference-count":88,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Lack of specific antiviral treatment for COVID-19 has resulted in long hospitalizations and high mortality rate. By harnessing the regulatory effects of adenosine on inflammatory mediators, we have instituted a new therapeutic treatment with inhaled adenosine in COVID-19 patients, with the aim of reducing inflammation, the onset of cytokine storm, and therefore to improve prognosis. The use of inhaled adenosine in COVID19 patients has allowed reduction of length of stay, on average 6 days. This result is strengthened by the decrease in SARS-CoV-2 positive days. In treated patients compared to control, a clear improvement in PaO<jats:sub>2<\/jats:sub>\/FiO<jats:sub>2<\/jats:sub>was observed together with a reduction in inflammation parameters, such as the decrease of CRP level. Furthermore, the efficacy of inhaled exogenous adenosine led to an improvement of the prognosis indices, NLR and PLR. The treatment seems to be safe and modulates the immune system, allowing an effective response against the viral infection progression, reducing length of stay and inflammation parameters.<\/jats:p>","DOI":"10.3389\/fimmu.2021.613070","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T05:11:32Z","timestamp":1616044292000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Efficacy and Effect of Inhaled Adenosine Treatment in Hospitalized COVID-19 Patients"],"prefix":"10.3389","volume":"12","author":[{"given":"Massimo","family":"Caracciolo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierpaolo","family":"Correale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmelo","family":"Mangano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Foti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmela","family":"Falcone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastiano","family":"Macheda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Cuzzola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Conte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella Consuelo","family":"Falzea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Iuliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Morabito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Caraglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Polimeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Ferrarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demetrio","family":"Labate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Tescione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Di Renzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano","family":"Chiricolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonino","family":"De Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.jinf.2020.04.030","article-title":"Clinical and transmission dynamics characteristics of 406 children with coronavirus disease 2019 in China: a review","volume":"81","author":"Zhen-Dong","year":"2020","journal-title":"J Infect"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3389\/fimmu.2020.01208","article-title":"Coronavirus disease (COVID-19): what are we learning in a country with high mortality rate?","volume":"11","author":"Mutti","year":"2020","journal-title":"Front Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","article-title":"Coronaviruses: an overview of their replication and pathogenesis","volume":"1282","author":"Fehr","year":"2015","journal-title":"Methods Mol Biol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu Rev Virol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"7988","DOI":"10.1073\/pnas.0409465102","article-title":"Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry","volume":"102","author":"Hofmann","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"key":"B7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1126\/science.abd3072","article-title":"Neuropilin-1 is a host factor for SARS-CoV-2 infection","volume":"370","author":"Daly","year":"2020","journal-title":"Science."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1002\/art.41285","article-title":"On the alert for cytokine storm: immunopathology in COVID-19","volume":"72","author":"Henderson","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"458","DOI":"10.15585\/mmwr.mm6915e3","article-title":"Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019\u2014COVID-NET, 14 states, March 1\u201330, 2020","volume":"69","author":"Garg","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1001\/jama.290.3.367","article-title":"Critically ill patients with severe acute respiratory syndrome","volume":"290","author":"Fowler","year":"2003","journal-title":"JAMA."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1099\/vir.0.055533-0","article-title":"Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment","volume":"94","author":"Lau","year":"2013","journal-title":"J Gen Virol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40425-018-0343-9","article-title":"Cytokine release syndrome","volume":"6","author":"Shimabukuro-Vornhagen","year":"2018","journal-title":"J Immunother Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/jmv.20255","article-title":"An interferon-gamma-related cytokine storm in SARS patients","volume":"75","author":"Huang","year":"2005","journal-title":"J Med Virol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ijcard.2005.01.068","article-title":"The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen","volume":"106","author":"Wilson","year":"2006","journal-title":"Int J Cardiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","article-title":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice","volume":"19","author":"Channappanavar","year":"2016","journal-title":"Cell Host Microbe"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1093\/infdis\/jit504","article-title":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis","volume":"209","author":"Zhou","year":"2014","journal-title":"J Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40495-020-00226-5","article-title":"Pipeline pharmacological therapies in clinical trial for COVID-19 pandemic: a recent update","author":"Kumari","year":"2020","journal-title":"Curr Pharmacol Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1080\/15548627.2018.1474314","article-title":"Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion","volume":"14","author":"Mauthe","year":"2018","journal-title":"Autophagy"},{"key":"B23","doi-asserted-by":"publisher","first-page":"104826","DOI":"10.1016\/j.phrs.2020.104826","article-title":"Darunavir does not prevent SARS-CoV-2 infection in HIV patients","volume":"157","author":"Riva","year":"2020","journal-title":"Pharmacol Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.12688\/f1000research.22457.2","article-title":"Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates","volume":"9","author":"Chen","year":"2020","journal-title":"F1000Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir\u2013ritonavir in adults hospitalized with severe COVID-19","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of COVID-19\u2014final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1056\/NEJMe2018715","article-title":"Remdesivir\u2014an important first step","volume":"383","author":"Dolin","year":"2020","journal-title":"N Engl J Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"10970","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B29","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12967-020-02339-3","article-title":"Why tocilizumab could be an effective treatment for severe COVID-19?","volume":"18","author":"Fu","year":"2020","journal-title":"J Transl Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.annonc.2020.03.300","article-title":"Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report","volume":"31","author":"Michot","year":"2020","journal-title":"Ann Oncol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.3389\/fimmu.2020.01942","article-title":"Case report: canakinumab for the treatment of a patient with COVID-19 acute respiratory distress syndrome","volume":"11","author":"Caracciolo","year":"2020","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.3389\/fimmu.2019.01633","article-title":"Purinergic signaling in pulmonary inflammation","volume":"10","author":"Le","year":"2019","journal-title":"Front Immun"},{"key":"B33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1179\/096805102125000470","article-title":"Lipopolysaccharide binds to and activates A(1) adenosine receptors on human pulmonary artery endothelial cells","volume":"8","author":"Wilson","year":"2002","journal-title":"J Endotoxin Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e6784","DOI":"10.1371\/journal.pone.0006784","article-title":"Selective deletion of the A1 adenosine receptor 514 abolishes heart-rate slowing effects of intravascular adenosine in vivo","volume":"4","author":"Koeppen","year":"2002","journal-title":"PLoS ONE"},{"key":"B35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/jcp.20138","article-title":"Animal models for the study of adenosine receptor function","volume":"202","author":"Yaar","year":"2005","journal-title":"J Cell Physiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1172\/JCI22656","article-title":"A protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury","volume":"115","author":"Sun","year":"2005","journal-title":"J Clin Invest."},{"key":"B37","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/414916a","article-title":"Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage","volume":"414","author":"Ohta","year":"2001","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1146\/annurev.immunol.22.012703.104731","article-title":"Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors","volume":"22","author":"Sitkovsky","year":"2004","journal-title":"Annu Rev Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.4049\/jimmunol.174.2.1073","article-title":"A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells","volume":"174","author":"Lappas","year":"2005","journal-title":"J Immunol."},{"key":"B40","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.4049\/jimmunol.158.11.5400","article-title":"Adenosine inhibits neutrophil degranulation in activated human whole blood: involvement of adenosine A2 and A3 receptors","volume":"158","author":"Bouma","year":"1997","journal-title":"J Immunol"},{"key":"B41","unstructured":"Istituto Superiore di Sanit\u00e0. Gli Studi interventistici per l'emergenza COVID-19 L'epidemiologiaper la sanit\u00e0 pubblica 2020"},{"key":"B42","doi-asserted-by":"publisher","first-page":"58","DOI":"10.18433\/jpps31002","article-title":"Current drugs with potential for treatment of COVID-19: a literature review","volume":"23","author":"Md","year":"2020","journal-title":"J Pharm Pharm Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e0239692.","DOI":"10.1371\/journal.pone.0239692","article-title":"Therapeutic effects of adenosine in high flow 21% oxygen aereosol in patients with COVID19-pneumonia","volume":"15","author":"Correale","year":"2020","journal-title":"PLoS ONE"},{"key":"B44","doi-asserted-by":"publisher","first-page":"E3045","DOI":"10.3390\/jcm9093045","article-title":"Can adenosine fight COVID-19 acute respiratory distress syndrome?","volume":"9","author":"Falcone","year":"2020","journal-title":"J Clin Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1165\/rcmb.2012-0351OC","article-title":"Macrophage A2A adenosinergic receptor modulates oxygen-induced augmentation of murine lung injury","volume":"48","author":"Aggarwal","year":"2013","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fncel.2019.00124","article-title":"Historical and current adenosine receptor agonists in preclinical and clinical development","volume":"13","author":"Jacobson","year":"2019","journal-title":"Front Cell Neurosci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1365-2125.1983.tb01481.x","article-title":"Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects","volume":"15","author":"Cushley","year":"1983","journal-title":"Br J Clin Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1369328","DOI":"10.1080\/20018525.2017.1369328","article-title":"Targeting the small airways with dry powder adenosine: a challenging concept","volume":"4","author":"van der Wiel","year":"2017","journal-title":"Eur Clin Respir J"},{"key":"B49","doi-asserted-by":"publisher","first-page":"4670","DOI":"10.3390\/ijms21134670","article-title":"Body composition findings by computed tomography in SARS-CoV-2 patients: increased risk of muscle wasting in obesity","volume":"21","author":"Gualtieri","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.3390\/nu11071526","article-title":"Effects of a personalized VLCKD on body composition and resting energy expenditure in the reversal of diabetes to prevent complications","volume":"11","author":"Romano","year":"2019","journal-title":"Nutrients"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1001\/jama.2012.5669","article-title":"Acute respiratory distress syndrome: the Berlin definition","volume":"307","author":"ARDS","year":"2012","journal-title":"JAMA."},{"key":"B52","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3109\/14397595.2015.1091136","article-title":"Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients","volume":"26","author":"Qin","year":"2016","journal-title":"Mod Rheumatol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1148\/radiol.2020200230","article-title":"CT imaging features of 2019 novel coronavirus (2019-nCoV)","volume":"295","author":"Chung","year":"2020","journal-title":"Radiology."},{"key":"B54","doi-asserted-by":"publisher","first-page":"102568","DOI":"10.1016\/j.autrev.2020.102568","article-title":"Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy","volume":"19","author":"Toniati","year":"2020","journal-title":"Autoimmun Rev."},{"key":"B55","unstructured":"WHO recommends against the use of remdesivir in COVID-19 patients.2020"},{"key":"B56","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1056\/NEJMoa2031304","article-title":"A randomized trial of convalescent plasma in COVID-19 severe pneumonia","volume":"384","author":"Simonovich","year":"2020","journal-title":"N Engl J Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.jamda.2020.04.022","article-title":"The importance of physical activity to care for frail older adults during the COVID-19 pandemic","volume":"21","author":"Aubertin-Leheudre","year":"2020","journal-title":"J Am Med Dir Assoc."},{"key":"B58","doi-asserted-by":"publisher","first-page":"001651","DOI":"10.12890\/2020_001651","article-title":"Anxiety and suicidality in a hospitalized patient with COVID-19 infection","volume":"7","author":"Epstein","year":"2020","journal-title":"Eur J Case Rep Intern Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"268","DOI":"10.34172\/aim.2020.09","article-title":"Epidemiology and clinical characteristics of COVID-19","volume":"23","author":"Huang","year":"2020","journal-title":"Arch Iran Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"101755","DOI":"10.1016\/j.tmaid.2020.101755","article-title":"An update on SARS-CoV-2\/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies","volume":"37","author":"Dhama","year":"2020","journal-title":"Travel Med Infect Dis."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2020.03.055","article-title":"pancreatic injury patterns in patients with coronavirus disease 19 pneumonia","volume":"159","author":"Wang","year":"2020","journal-title":"Gastroenterology."},{"key":"B63","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet."},{"key":"B64","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1038\/s41467-020-17292-42020","article-title":"Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia","volume":"11","author":"De","year":"2020","journal-title":"Nat Commun."},{"key":"B65","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00592-009-0109-4","article-title":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes","volume":"47","author":"Yang","year":"2010","journal-title":"Acta Diabetol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/path.1560","article-title":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways","volume":"203","author":"Ding","year":"2004","journal-title":"J Pathol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","year":"2020","journal-title":"Nat Microbiol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"262","DOI":"10.7326\/M20-1495","article-title":"Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure","volume":"173","author":"Kucirka","year":"2020","journal-title":"Ann Intern Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"eabd0110","DOI":"10.1126\/sciimmunol.abd0110","article-title":"Inhibition of Bruton tyrosine kinase in patients with severe COVID-19","volume":"5","author":"Roschewski","year":"2020","journal-title":"Sci Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fimmu.2019.00119","article-title":"The immunology of macrophage activation syndrome","volume":"10","author":"Crayne","year":"2019","journal-title":"Front Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"107233","DOI":"10.1016\/j.carpath.2020.107233","article-title":"The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities","volume":"48","author":"Buja","year":"2020","journal-title":"Cardiovasc Pathol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nature10759","article-title":"Inflammasomes in health and disease","volume":"481","author":"Strowig","year":"2012","journal-title":"Nature."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/ni.1671","article-title":"Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens","volume":"9","author":"El","year":"2008","journal-title":"Nat Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1161\/ATVBAHA.111.226852","article-title":"Regulation of macrophage function by adenosine","volume":"32","author":"Hask\u00f3","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"7212","DOI":"10.4049\/jimmunol.180.11.7212","article-title":"Effect of A2B adenosine receptor gene ablation on proinflammatory adenosine signaling in mast cells","volume":"180","author":"Ryzhov","year":"2008","journal-title":"J Iimmunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/BF00171056","article-title":"Adenosine A2A receptors mediate the inhibitory effect of adenosine on formyl-Met-Leu-Phe-stimulated respiratory burst in neutrophil leucocytes","volume":"354","author":"Fredholm","year":"1996","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s11302-006-9019-x","article-title":"Novel selective antagonist radioligands for the pharmacological study of A(2B) adenosine receptors","volume":"2","author":"Gessi","year":"2006","journal-title":"Purinergic Signal."},{"key":"B79","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.thromres.2007.08.014","article-title":"Gene expression profiling for the identification of G-protein coupled receptors in human platelets","volume":"122","author":"Amisten","year":"2008","journal-title":"Thromb Res."},{"key":"B80","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2019","journal-title":"JAMA Intern Med"},{"key":"B81","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1096\/fj.11-190934","article-title":"Adenosine promotes alternative macrophage activation via A2A and A2B receptors","volume":"26","author":"Cs\u00f3ka","year":"2012","journal-title":"FASEB J"},{"key":"B82","doi-asserted-by":"publisher","first-page":"7726","DOI":"10.4049\/jimmunol.172.12.7726","article-title":"Adenosine-activated mast cells induce IgE synthesis by B lymphocytes: an A2B-mediated process involving Th2 cytokines IL-4 and IL-13 with implications for asthma","volume":"172","author":"Ryzhov","year":"2004","journal-title":"J Immunol (Baltimore, Md.: 1950)."},{"key":"B83","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ebiom.2019.09.030","article-title":"Adenosine in pancreatic cancer: emerging combination therapies","volume":"48","author":"Roth","year":"2019","journal-title":"EBioMedicine."},{"key":"B84","doi-asserted-by":"publisher","first-page":"110012","DOI":"10.1016\/j.mehy.2020.110012","article-title":"Targeting adenosinergic pathway and adenosine A2A receptor signaling for the treatment of COVID-19: a hypothesis","volume":"144","author":"Abouelkhair","year":"2020","journal-title":"Med Hypotheses."},{"key":"B85","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4055\/cios.2014.6.1.103","article-title":"How to do random allocation (randomization)","volume":"6","author":"Kim","year":"2014","journal-title":"Clin Orthop Surg."},{"key":"B86","doi-asserted-by":"publisher","first-page":"e00631","DOI":"10.1002\/prp2.631","article-title":"Hypothesis: pentoxifylline is a potential cytokine modulator therapeutic in COVID-19 patients","volume":"8","author":"Hendry","year":"2020","journal-title":"Pharmacol Res Perspect"},{"key":"B87","doi-asserted-by":"publisher","first-page":"107209","DOI":"10.1016\/j.intimp.2020.107209","article-title":"Pentoxifylline decreases serum LDH levels and increases lymphocyte count in COVID-19 patients: results from an external pilot study","volume":"90","author":"Maldonado","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1365-2125.1987.tb03053.x","article-title":"Intravenous infusion of adenosine but not inosine stimulates respiration in man","volume":"23","author":"Reid","year":"1987","journal-title":"Br J Clin Pharmacol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.613070\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T10:04:01Z","timestamp":1698055441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.613070\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,18]]},"references-count":88,"alternative-id":["10.3389\/fimmu.2021.613070"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.613070","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,18]]},"article-number":"613070"}}